The simultaneous overexpression of RFPL3, CBP and hTERT predicted relatively poor prognosis of lung cancer patients, suggesting the most potential significance to inhibit lung cancer cell growth by downregulating the RFPL3/CBP/hTERT signaling pathway. The gene discussed is CREBBP; the disease is lung cancer.